Details of the Drug

General Information of Drug (ID: DMYENTG)

• Drug Name: TLPLDC

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]
Ovarian cancer	2C73	Phase 1/2	[2]

• Cross-matching ID: TTD ID: D0D0DH
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT02301611) Phase IIB TL + YCWP + DC in Melanoma. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)